baber/WOPTO huggingface dataset:
Patent JP-3731004-B2 (JP)
IPC: C12N15/62
Filed: 1995-01-31
Granted: 2006-01-05
Abstract: The invention provides a DNA construct comprising the <u>htrA</u> promoter sequence operably linked to a DNA sequence encoding one or more heterologous proteins, replicable expression vectors containing the constructs, and attenuated bacteria containing the constructs or vectors. The invention also provides a vaccine composition comprising an attenuated bacterium as defined above, or a fusion protein expressed from a construct as defined above, and a pharmaceutically acceptable carrier.
Patent MD-4066-B2 (MD)
Inventor: ERMURATSCHII VLADIMIR
IPC: F24S23/77
Filed: 2008-09-01
Abstract: Inventia se refera la domeniul termoenergeticii, in particular la dispozitivele pentru transformarea energiei naturale: radiatiei solare in energie termica, a energiei atmosferei si cosmosului in frig, si poate fi aplicata in sistemele de alimentare cu caldura si frig natural. Colectorul-acumulator contine o camera termoizolata (1) in forma de paralelipiped sau trunchi de piramida cu invelis (2) transparent pentru radiatia electromagnetica. In interior camera (1) este divizata prin pereti despartitori in sectoare si printr-un planseu (3) intr-un compartiment de plafon (4). Fiecare sector este divizat prin rafturi (13) in caturi, pe care sunt instalate elemente de acumulare (14). In compartimentul de plafon (4) este instalat un absorbitor/radiator, de exemplu, in forma de un sir de plase innegrite (5), sub care este instalat un schimbator de caldura (6) fara acumulare de apa. Sectoarele si compartimentul de plafon (4) sunt dotate cu capace (16) cu reflectoare si canale pentru agentul termic gazos. Colectorul-acumulator contine o cutie (7), divizata in conducte de gaze, care comunica cu sectoarele si compartimentul de plafon (4), si un sistem de circulare a agentului termic cu elemente de inchidere si de reglare (27). Rezultatul inventiei consta in multitudinea de variante ale regimurilor de functionare a colectorului-acumulator, functionarea cu agenti termici gazos si lichid, simplitatea constructiei.
Patent ES-2214949-B2 (ES)
Title: Aparato para la validacion y almacenaje de billetes.
Inventor: GUINDULAIN VIDONDO FELIX
IPC: G07D11/00
Filed: 2002-07-31
Granted: 2006-02-01
Abstract: Aparato para la validación y almacenaje de billetes, de uso principal en máquinas automáticas expendedoras de productos así como recreativas de juego y premio, comprendiendo el aparato (1) un cabezal (2) para la validación de los billetes y un elemento (3) para el almacenaje de los billetes validados como válidos, definiéndose el cabezal (2) por la unión abisagrada de dos cuerpos (4) y (5), adosados según una superficie en "L", incorporando el cabezal (2) una serie de medios para la validación de los billetes, en tanto que el elemento (3) para el almacenaje de los billetes presenta un alojamiento (34) provisional, definido como prolongación del canal (6) del cabezal y un compartimento (37) definitivo de almacenaje.
Patent ES-2388213-B2 (ES)
Inventor: ENCINAR GARCINUNO JOSE ANTONIO
IPC: G02F1/1333
Filed: 2010-12-16
Granted: 2013-01-29
Abstract: The invention relates to a reconfigurable beam reflectarray antenna for frequencies in the terahertz and millimeter-wave range. The reflectarray antenna consists of a flat array of phase-shifter cells (reflectarray) illuminated by a feeder, which produces an electronically reconfigurable collimated or shaped beam, in which the phase-shifter cells are formed by multiple stacked layers of conductive elements on a dielectric substrate, alternated with layers of liquid crystal and a conductive plane. By applying bias voltages to the conductive elements, the dielectric constant of the liquid crystal is varied, thereby producing a phase shift in the reflected field in each phase shifter cell and allowing electronic beam scanning or reconfiguration to be performed. The bandwidth and the performance of the beam scanning or reconfiguration are improved by including multiple layers of conductive elements and liquid crystal. The antenna is suitable for observation satellites, communications and security systems.
Patent ES-2455940-B2 (ES)
Title: Pluviómetro.
Inventor: SANCHEZ MARTOS ANTONIO JES S
IPC: G01W1/14
Filed: 2012-12-27
Granted: 2014-07-30
Abstract: Pluviómetro, que comprende un colector de lluvia (1), una probeta inferior de medición (3) y un envase inferior de almacenamiento (4), todos ellos fijados sobre una plataforma (1) mediante acoplamientos tipo bayoneta.#La plataforma (1) dispone de un ensanchamiento radial (20) que conforma inferiormente un alojamiento para la fijación de un poste soporte (23) y superiormente una cavidad (22) para un nivel de burbuja (26).
Patent AU-2001267051-B2 (AU)
Title: Mitigation of radio frequency interference in mulitcarrier transmission
Inventor: RAMIREZ-MIRELES FERNANDO
IPC: H04L27/26
Filed: 2001-06-08
Granted: 2004-11-11
Abstract: A multi-carrier modulation transceiver and a method for multi-carrier modulation communication are proposed. One or more tones are disabled during initialization based on a received tone-disable message. A multi-carrier receiver can determine the message that specifies one or more tones that are to be disabled during initialization.
Patent AU-2001291154-B2 (AU)
Title: A novel life-saving device
Inventor: DORITY JOHN B
IPC: B63C9/26
Filed: 2001-09-20
Granted: 2005-10-06
Abstract: A novel life-saving device (Fig. 1D) comprising a buoyant disk having a top side, a bottom side, a leading edge and a cavity on the bottom side along and adjacent to the leading edge, the cavity having an inner side generally parallel to the leading edge the inner side having an upper edge and a lower edge and a length of line affixed through and about the center of the bouyant disk generally paralell to the leading edge and disposed around the inner side of the cavity.
Patent AU-2002340825-B2 (AU)
Title: HDL for the treatment of stroke and other ischemic conditions
Inventor: PATERNO ROBERTO
IPC: A61P9/10
Filed: 2002-08-20
Granted: 2007-07-05
Abstract: The present invention relates to a method for the prophylaxis and/or treatment of stroke and other ischemic injury, wherein HDL is administered to a subject in need thereof, particularly by intravenous infusion.
Patent AU-2003204769-B2 (AU)
Title: Trim-type fastener driving tool
Inventor: LARGO MARC
IPC: B25C5/16
Filed: 2003-06-18
Granted: 2008-07-24
Abstract: A powered tool (10) constructed to drive a fastener (16) into a workpiece (20) includes a nosepiece assembly (12) including a back plate (24) and a front plate (26) combining to define a path (28) for a driver blade (30), the front plate (26) being pivotally movable relative to the back plate (24) between a closed position, in which the front plate (26) and the back plate (24) are in contact with each other, and an open position. The front plate (26) is movable to an interim deflecting position between the closed position and the open position. A handle portion (90) has an outer surface at least partially defining a grip, and an inner surface at least partially defining a chamber (92). The handle portion (90) includes a substrate having at least one aperture, and an overmold (102) configured for forming a gripping surface on the outer surface and for extending through the apertures into the chamber for forming a resilient mounting point. <IMAGE>
Patent AU-2003239357-B2 (AU)
Title: Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
Inventor: STEARNS MARK
IPC: G01N33/574
Filed: 2003-05-07
Granted: 2010-05-20
Abstract: The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer. The invention further relates to methods of detecting and treating prostate cancer, comprising modulating or detecting PCADM-1 expression and/or production and activity of PCADM-1 polypeptide. Further, the invention relates to novel assays for the identification of DNA-binding proteins and the double-stranded oligonucleotide sequences that specifically bind with them. Finally, the invention relates to DNAZYMs or DNA enzymes which specifically bind PCADM-1 mRNA to inhibit PCADM-1 gene expression and thereby destroy tumor cells and tumor tissue.
Patent AU-2003253503-B2 (AU)
Title: Process for increasing the capacity of a urea plant
Inventor: TJIOE TJAY TJIEN
IPC: C07C273/12
Filed: 2003-07-10
Granted: 2009-08-20
Abstract: Process for increasing the capacity of a urea plant comprising a compression section, a high-pressure synthesis section, a urea recovery section, in which a urea melt is formed, and optionally a granulation section, the capacity of the urea plant being increased by the additional installation of a melamine plant and the urea melt from the urea recovery section of the urea plant being fed wholly or partly to the melamine plant and the residual gases from the melamine plant being returned wholly or partly to the high-pressure synthesis section and/or the urea recovery section of the urea plant.
Patent AU-2003254495-B2 (AU)
Title: Polypeptides with a signal sequence comprising an FIVSI motif and polynucleotides encoding therefor
Inventor: SLEEP DARRELL
IPC: C12N15/62
Filed: 2003-07-23
Granted: 2009-03-26
Abstract: The present invention provides a method for improving a leader sequence by insertion of a pentapeptide motif comprising -X 1 -X 2 -X 3 -X 4 -X 5 - and a polypeptide comprising (i) a leader sequence, the leader sequence comprising a (a) secretion pre sequence, and (b) the following motif: 
-X 1 -X 2 -X 3 -X 4 -X 5 - 
where X 1  is phenylalanine, tryptophan, or tyrosine, X 2  is isoleucine, leucine, valine, alanine or methionine, X 3  is leucine, valine, alanine or methionine, X 4  is serine or threonine and X 5  is isoleucine, valine, alanine or methionine; and (ii) a desired protein heterologous to the leader sequence. A polypeptide of the invention may additionally comprise, as part of the leader sequence, a secretion pro sequence. The invention also provides a polynucleotide comprising a sequence that encodes a polypeptide of the invention and a cell, preferably a yeast cell, comprising said polynucleotide.
Patent AU-2004232456-B2 (AU)
Title: Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
Inventor: WOHLFART PAULUS
IPC: C07D471/14
Filed: 2004-04-13
Granted: 2010-06-17
Abstract: A triaza- and tetraaza-anthracenedione derivatives, its stereoisomeric forms or mixture, or salts are new. A triaza- and tetraaza-anthracenedione derivatives of formula (I), its stereoisomeric forms or mixture, or salts are new. [Image] A : CR 6 or N; B : CR 7 or N; R 11-10C alkyl, 3-8C cycloalkyl, 2-10C alkenyl or 2-10C alkynyl (all optionally substituted by halo, CN, 3-8C cycloalkyl, phenyl, biphenylyl, naphthyl, indanyl or heteroaryl); R 2H, 1-4C alkyl, CF 3, -(CH 2) a-3-8C cycloalkyl, -(CH 2) a-phenyl, -(CH 2) a-imidazolyl or -(CH 2) a-pyridinyl; a : 0 - 2; R 3-(CH 2) b-phenyl, -(CH 2) b-imidazolyl, -(CH-2) b-triazolyl, -(CH 2) b-Het or -(CH 2) b-pyridinyl; b : 1 - 4; R 4 - R 7H, 1-4C alkyl, CF 3, 1-4C alkoxy, OCF 3, halo, nitro, CN, -CO-R 1 0, -NR 8R 9, -NH-CO-1-4C alkyl, -SO 2-NR 8R 9, -SO 2-1-4C alkyl or -SO 2-(CH 2) c-phenyl; c : 0 - 2; R 8 and R 9H or 1-4C alkyl; R 1 0OH, 1-4C alkoxy or -NR 8R 9; Het : a residue of a saturated 5- or 6-membered monocyclic heterocycle (contains a ring nitrogen via which it is bonded, and additionally contains a further ring heteroatom selected from N, O and S, and optionally substituted by 1-4C alkyl or -(CH 2) d-phenyl); d : 0 - 2; Heteroaryl : a residue of an aromatic 5 - 10 membered, monocyclic or bicyclic heterocycle (contains 1 - 4 N, O and S). The residues phenyl, biphenylyl, naphthyl, indanyl, heteroaryl, pyridinyl, imidazolyl and triazolyl are optionally substituted by halo, CN, 1-6C alkyl, CF 3, 1-6C alkoxy or OCF 3. A and B are not simultaneously N. An independent claim is included for preparation of (I). ACTIVITY : Cardiovascular-Gen.; Antianginal; Cardiant; Cerebroprotective; Vasotropic; Thrombolytic; Antiarteriosclerotic; Hypotensive; Respiratory-Gen.; Nephrotropic; Antiarrhythmic; Antidiabetic; Ophthalmological; Antiasthmatic; Antiangiogenic; Hepatotropic; Osteopathic. MECHANISM OF ACTION : Endothelial nitric oxide (NO) synthase (eNOS) expression stimulator. (4S)-9-(3-(Imidazo)-1-yl)propyl)-4-isopropyl-6-nitro-2-(4-phenylbutyl)-1,2,9,9a-tetrahydro-2,4a,9-triaza-anthracene- 3,10(4H)-dione trifluoroacetic acid (Ia) was tested for activation of eNOS transcription as described in Li et al., Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene, Mol. Pharmacol. 53 (1998) 630. (Ia) Showed an EC 5 0 of 2.2 mM.
Patent AU-2004322006-B2 (AU)
Title: Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation
Inventor: NA HYE-KYUNG
IPC: C07K1/12
Filed: 2004-07-31
Granted: 2012-05-24
Abstract: The present invention relates to silk peptide having neuroprotective and neurofunctional activities and its preparation method, and more particularly relates to a method of preparing silk protein preferably having neuroprotective activity with weight average molecular weight of 200-100,000 by hydrolysis of silk fibroin; a composition for preventing or treating brain disease comprising silk peptide and pharmaceutically acceptable carrier; and a composition for improving brain function.
Patent AU-2004322654-B2 (AU)
Title: Method and apparatus for reducing noise in a roots-type blower
Inventor: MALCOLM WILLIAMS
IPC: F04C18/12
Filed: 2004-11-10
Granted: 2011-11-10
Abstract: A Roots-type blower comprises a housing defining a rotor chamber and an inlet and outlet to the rotor chamber. First and second rotors are mounted in the rotor chamber, each rotor defining a plurality of lobes, adjacent lobes and the housing cooperating to define gas transport chambers. The blower is configured so that a net flow rate of gas into a gas transport chamber is generally or approximately constant, whereby a change in gas pressure in the gas transport chamber is generally or approximately linear, as the gas transport chamber approaches the outlet. In one embodiment, this is accomplished by providing flow channels extending from the outlet towards the inlet, and from the inlet towards the outlet, corresponding to each rotor. The flow channels permit gas to flow from the high pressure outlet to a gas transport chamber and from the gas transport chamber to the low pressure inlet. The resulting amelioration of pressure spikes associated with flow back substantially reduces the operational noise level of the blower.
Patent AU-2005257715-B2 (AU)
Title: Means and method for detection of blood leakage from wounds
Inventor: ENGVALL DANIEL
IPC: H04B10/25
Filed: 2005-06-21
Granted: 2010-04-22
Abstract: An optical fibre through which light passes is used for detecting blood leakage from a wound. The fibre may be comprised by a blood leakage detection apparatus having a light source and a photo detector in radiative communication with the respective ends of the fibre and producing an electrical signal in response to the light detected, photo detector signal amplifying means, means for detecting changes in the amplified signal over time, and alarm means, wherein a decrease in signal strength during a selected time period activates the alarm means; a corresponding method of detecting blood leakage; a device for use with the apparatus of the invention comprising the optical fibre thereof provided with coupling means at its ends and a patch of blood absorbing material.
Patent AU-2005318598-B2 (AU)
Title: Tetralin and indane derivatives and uses thereof as 5-HT antagonists
Inventor: KRESS JAMES M
IPC: C07D211/58
Filed: 2005-12-12
Granted: 2010-08-26
Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, p, q, Ar, R1 and R2 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.
Patent AU-2006251768-B2 (AU)
Title: Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
Inventor: SHARMA RAJIV
IPC: A61P3/10
Filed: 2006-05-18
Granted: 2009-09-10
Abstract: The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally substituted thiazole ring; and R1 has the values provided herein. The present invention also provides compositions, uses, and methods for use of the compounds, for instance, for treatment of type II diabetes.
Patent AU-2006259666-B2 (AU)
Title: Multiplexed polymerase chain reaction for genetic sequence analysis
Inventor: SCHNUR JOEL M
IPC: C12P19/34
Filed: 2006-06-09
Granted: 2011-08-25
Abstract: A PCR method involving: providing a biological sample suspected of containing one or more pathogen nucleic acids; adding a plurality of PCR primers corresponding to genes found in the pathogens; and performing a polymerase chain reaction on the sample to amplify a subset of the nucleic acids that correspond to the genes. The primers include at least one primer pair for each pathogen, and the primers contain a tail sequence that is not homologous any pathogen DNA or to any background DNA in the sample. The concentration of at least one primer in the polymerase chain reaction is no more than about 100 nM.
Patent AU-2006271395-B2 (AU)
Title: Membrane-translocating peptides
Inventor: KEVIN FITZGERALD
IPC: C12N15/10
Filed: 2006-07-24
Granted: 2011-08-18
Abstract: A method is provided for selecting membrane-translocating peptides (MTPs) from a peptide display library that are capable of crossing or penetrating a lipid membrane. A plurality of nucleic acid constructs that encode displayed peptides are expressed, resulting in the formation of a plurality of nucleic acid-peptide complexes, each complex comprising at least one displayed peptide associated with the corresponding nucleic acid construct encoding the displayed peptide; the complexes are exposed to a population of membrane-encapsulated compartments, allowing a translocating reaction to occur; complexes that remain unassociated with the membrane are removed; optionally complexes that are associated with the membrane are removed; and internalised nucleic acid-peptide complexes are recovered. The membrane-encapsulated compartments may be artificial vesicles such as liposomes, or populations of one or more cell types.
Patent AU-2006329198-B2 (AU)
Title: Novel cancer-associated antigen
Inventor: CHAHAL FRANCINA C
IPC: C07K14/05
Filed: 2006-12-21
Granted: 2012-02-02
Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
Patent AU-2006338182-B2 (AU)
Title: Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
Inventor: NITZEL GREG
IPC: A61K39/12
Filed: 2006-12-28
Granted: 2013-08-22
Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (PCV2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection. Preferably, they include lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes. Moreover, the clinical symptoms include lymphadenopalhy in combination with one or a multiple of the following symptoms in pigs: (1) interstitial pneumonia with interlobular edema, (2) cutaneous pallor or icterus, (3) mottled atrophic livers, (4) gastric ulcers, (51 nephritis and (6) reproductive disorders, e.g. abortion, stillbirths. mummies, etc. Furthermore the clinical symptoms include Pia like lesions, normally known to be associated with Lawsonia intracellularis infections.
Patent AU-2006343427-B2 (AU)
Title: Multi function wrapper
Inventor: DREVIK SOLGUN
IPC: B65D85/07
Filed: 2006-05-04
Granted: 2013-04-18
Abstract: The invention refers to a packing wrapper (2) for an absorbent article (1), the wrapper (2) comprising a protective layer (5). The invention is characterised in that the wrapper (2) comprises also a first functional layer (3) attached to the protective layer (5) giving the wrapper (2) a multiple functionality.
Patent AU-2007201958-B2 (AU)
Title: Monolithic cylinder-crankcase
Inventor: BROWER DAVID R
IPC: F02F1/00
Filed: 2007-05-02
Granted: 2013-05-16
Abstract: A cylinder-crankcase is disclosed that includes a cylinder block having a cylinder head for receiving a spark plug. The cylinder-crankcase also includes a 5 crankcase and a crank arm for supporting a crankshaft. The cylinder block, cylinder head, crankcase and crank arm are a single, monolithic piece.
Patent AU-2007209959-B2 (AU)
Title: Biogenic fuel gas generation in geologic hydrocarbon deposits
Inventor: ULRICH GLENN A
IPC: E21B43/22
Filed: 2007-01-29
Granted: 2011-10-27
Abstract: A method to stimulate the biogenic production of a metabolite with enhanced hydrogen content that includes forming an opening in a geologic formation to provide access to a consortium of microorganisms, and injecting water into the opening to disperse at least a portion of the consortium over a larger region of a hydrocarbon deposit. The method may also include measuring a change in the rate of production of the metabolite in the formation. Also, an method to stimulate biogenic production of a metabolite that includes measuring a salinity level of formation water in a geologic formation, and injecting water into the opening to reduce the salinity level of the formation water in the formation. The method may also include measuring a change in the rate of production of the metabolite in the formation.
Patent AU-2007231791-B2 (AU)
Title: Lock assembly adaptor
Inventor: CONSTANTINOU JOHN
IPC: E05B15/12
Filed: 2007-11-05
Granted: 2012-11-15
Abstract: This invention relates to an adaptor 14 for use with a lock assembly 1. The adaptor includes a mount 15 which is fixed in position relative to a housing 12 of the lock assembly 1. A detent 18 is movable relative to the mount 15 between an inactive position whereby the bolt is movable relative to the housing to an extended lock position, and an inactive position whereby the bolt is not movable relative to the housing to a lock position. The adaptor also includes biasing means 20 for urging the detent 18 towards the active position. W:sharonbrad\Complete Applicatons\ASSA - Lock Assembly Adaptor 29 Oct 07doc - 16
Patent AU-2007245386-B2 (AU)
Title: Method of identifying predictive lateral load transfer ratio for vehicle rollover prevention and warning systems
Inventor: LEW JAE Y
IPC: B60W30/02
Filed: 2007-05-03
Granted: 2011-06-02
Abstract: A method for controlling stability of a vehicle includes the steps of determining a predictive lateral load transfer ratio of the vehicle by evaluating vehicle performance factors over a period of time, and controlling operation of the vehicle based on the predictive lateral load transfer ratio.